Why a Ban on 7-OH Would Create a Public Health Crisis, Not Solve One

America is in the middle of a drug overdose epidemic that has claimed more than 100,000 lives annually in recent years. Synthetic opioids—particularly fentanyl—are the leading cause of death for Americans ages 18 to 45. Against this backdrop, lawmakers in several states are considering banning a naturally occurring compound known as 7-hydroxymitragynine (7-OH), a metabolite of the kratom plant that many individuals are using as a safer alternative to prescription opioids, alcohol, and other addictive substances.

Banning 7-OH may seem like a precautionary move—but the reality is that such a ban could backfire, eliminating a key harm reduction tool and driving people back toward far more dangerous substances. The science, the lived experiences, and the regulatory context all point to one conclusion: prohibiting 7-OH would create a public health crisis, not solve one.

A Safer, Natural Alternative That’s Already Helping Thousands

7-OH is not a synthetic lab drug. It’s a naturally occurring alkaloid found in trace amounts in the kratom plant and is also produced inside the human body when kratom’s primary compound, mitragynine, is metabolized by the liver. In fact, studies show that 21–31% of mitragynine is converted into 7-OH inside the body, depending on the dose.

What makes 7-OH unique—and important—is its partial activation of the brain’s mu-opioid receptor. Unlike heroin or fentanyl, which fully activate these receptors and can suppress breathing to the point of overdose, 7-OH is a partial agonist with a ceiling effect, meaning there’s a natural limit to its action. This reduces the risk of respiratory depression and overdose.

According to published research and ongoing safety studies:

• There is no known LD50 (lethal dose) for 7-OH

• It does not significantly activate the beta-arrestin2 pathway, which is a known driver of opioid overdose

• It has shown promise for pain management, mood stabilization, and reduced alcohol intake in preclinical studies
  

The Risk of Taking Away a Harm Reduction Option

Across the country, thousands of people are using 7-OH products to manage chronic pain, mental health conditions, and recovery from addiction. In testimonials submitted to organizations like the 7-HOPE Alliance and HART, users describe using 7-OH to taper off heroin, fentanyl, and Suboxone; manage PTSD, BPD, and depression; and find energy and focus without prescription drugs.

Many say it is the only thing that has worked for them, especially in states where access to medical cannabis or opioid alternatives is limited. Others have turned to 7-OH after conventional recovery tools failed. To take this option away—without providing a safer or more effective alternative—would be devastating.

This isn’t just theoretical. In its decision not to schedule kratom or its components, the U.S. Department of Health and Human Services explicitly cited the “significant risk of immediate adverse public health consequences for potentially millions of users” if access were eliminated.

Regulation Works. Prohibition Doesn’t.

Some lawmakers are considering banning 7-OH under the belief that it is a synthetic opioid or that it hasn’t been studied enough. But these assumptions don’t hold up under scrutiny.

Most importantly, 7-OH is not synthetic. It is either metabolized naturally in the body or derived from kratom using oxidation—a simple process comparable to how other natural supplements (like Delta-8 THC or stabilized vitamin C) are made. Its production is fully consistent with dietary supplement practices.

The idea of a 1% or 2% cap on 7-OH is also flawed. These caps are based on arbitrary percentages rather than actual milligram limits per serving. As experts have noted, a 2% cap can actually encourage more dangerous product formulations by forcing manufacturers to combine high levels of mitragynine to “balance” the 7-OH content—ironically increasing the liver burden and potential toxicity.

Instead of bans or caps, science-based regulation is the answer. Industry groups like HART are actively pursuing federal and state legislation to ensure all 7-OH products are:

• GMP-compliant and tested for contaminants

• Clearly labeled with serving sizes and warnings

• Kept out of the hands of minors

• Manufactured to standardized, safe limits

Misinformation Has Consequences

The campaign to ban 7-OH has been riddled with misinformation. Some opponents have labeled 7-OH as “gas station heroin”—a phrase rooted in marketing, not science. Others have pointed to kratom-related death reports without acknowledging that more than 95% of these cases involved multiple substances or adulterants.

Even studies often cited by critics don’t claim that 7-OH is unsafe when used responsibly. Instead, they emphasize the need for more research—which is exactly what the 7-HOPE Alliance and HART are doing. Pre-clinical studies on liver toxicity, pharmacokinetics, enzyme metabolism, and tolerability are already underway, with results expected this year and into 2026.

A Ban Doesn’t Eliminate Demand—It Eliminates Safety

We’ve seen what happens when substances are banned without addressing underlying demand. It pushes people to the illicit market, where products are unregulated, mislabeled, and often dangerous. A ban on 7-OH would do the same. It would open the door for black market products, unsafe mixtures, and desperate consumers turning back to fentanyl, alcohol, or unregulated kratom extracts.

In contrast, a legal, regulated market keeps people safe, encourages transparency, and supports public health goals. And for many individuals—especially those in recovery—access to 7-OH is the difference between progress and relapse.

Let Science Lead, Not Stigma

The facts are clear: banning 7-OH would do more harm than good. It would strip away a promising harm reduction tool at a time when America desperately needs more of them. It would punish responsible users while doing nothing to solve the underlying crisis of addiction, chronic pain, or inadequate access to alternative therapies.

We don’t need fear-based policies. We need science-based regulation, continued research, and compassion for those who are trying to manage their health in the safest way possible.

Let’s protect access. Let’s fund the science. And let’s stop pretending that prohibition is a public health strategy.